Chagas disease etiology: autoimmunity or parasite persistence?
about
Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in miceA cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infectionGalectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac CellsPathogenesis of chagas' disease: parasite persistence and autoimmunityMolecular mimicry may contribute to pathogenesis of ulcerative colitis.Trypanosoma cruzi mitochondrial maxicircles display species- and strain-specific variation and a conserved element in the non-coding regionHLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.Profile of central and effector memory T cells in the progression of chronic human chagas diseaseDNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infectionTrypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal.DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi geneGenetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infectionTrypanosoma cruzi in persons without serologic evidence of disease, ArgentinaInhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infectionTrypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells.A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas diseaseValue of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.Myocarditis, microbes and autoimmunity.Innate and acquired immunity in the pathogenesis of Chagas disease.Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.Role of autoantibodies in the physiopathology of Chagas' disease.Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations.Trypanocidal drugs: mechanisms, resistance and new targets.Advances and challenges towards a vaccine against Chagas disease.Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence.Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts.NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infectionEvidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune responseAnalysis of association of FOXO3 gene with Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy.Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruziPerspectives of vaccination in Chagas disease revisited.PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.
P2860
Q24602785-EE5109BA-6308-4CB8-AB4B-430F888F4BEBQ24684717-F1253124-C5A1-4E64-B6A1-2A1F40AA0897Q27303934-2A1D52F3-F168-4A09-B8B3-D7CB8E62AC23Q28742827-2748A353-F894-460B-99DD-E25615047D5DQ31162559-155B7E6A-4EBB-4962-AFCA-CE4EC5B6E8F8Q33237291-14FD215A-B7CC-465B-9941-C3CDB66D3A24Q33375075-7533F0A2-5233-4B2E-841B-E629ED22EEEEQ33501719-97FA619D-E055-427D-BBED-E362A80D9CA5Q33597941-141F32BC-00F0-4CD8-839C-2B833FDD167AQ33911077-4D7DC458-AA0C-4CD0-83B3-70E3D8D06517Q34008901-BAE680F1-A981-4D2B-8890-8E0EA70D798AQ34131388-F8B1BAF6-F906-46AF-9963-14BDF5F3346FQ34554966-24925A10-06D2-487D-AB3F-B7CE1F6560C7Q35035389-90AFFE41-6CEF-42D6-8526-C059C9F4455FQ35154144-FC78ED62-D6B9-46A2-ABC3-C120F6845049Q35565140-EF63A92A-ED12-4701-A3E6-C05CD27CC88BQ35582424-B3A1A217-8061-4CE8-8AD4-A6230A9135D1Q35884259-02588807-24C9-4F9E-87AA-41516D0ABF67Q35994765-4782F938-BA37-48A7-8AA8-21EB69A143C9Q35994773-2FF392AC-F9E3-4CF6-91A2-8654B94E23C2Q36154765-ADE5692E-194E-43FB-AD5B-F4E3567BE206Q36229272-2447A33F-B070-4567-9D88-A14F764036ADQ36422127-78674DA5-B34F-4AA8-8E7C-840A34A7DD30Q37325527-3973A8A6-A4F0-472A-B2A5-CA7D1AC4EEBDQ37597052-FD212A40-2DE1-4116-8FCD-76B3321148BCQ37623081-3DC55F7B-BE4F-47CD-9929-8C12647563D9Q37952062-3CF105FA-F8AC-4265-9314-A7972D489EBEQ37984645-7899A592-CD15-4674-828C-6710C63B5AF6Q38286350-FDC61299-C5D0-446C-9144-348C2C33499DQ38364470-B8AC3374-B9BA-44F5-B99F-56B34051B7A3Q39146653-1D4CF7FF-5552-4AE1-8604-C94446C3209BQ39179244-85BAF88C-C391-480E-B3B7-1E52646EF9F6Q39179252-CEC3E56F-FED6-41F4-90B5-6D362F26B08FQ39282283-06D03393-C7AD-46BE-AA14-2FF02AB3E0E0Q39419338-8D3D20FD-CAE4-4453-83D7-91B436B25035Q39730057-8CA728C4-396A-4708-8816-276C7C5521AEQ39813174-97F5EEEA-A19F-42C7-B674-4DA55CC57BD4Q39829243-572A4E92-8090-4942-9255-DB3B1E489F93Q39945086-19208CF0-D86F-443B-A397-3AF13A34E2F5Q40173043-DFF3A2F3-6B40-4A69-81D0-5371F6D718E3
P2860
Chagas disease etiology: autoimmunity or parasite persistence?
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Chagas disease etiology: autoimmunity or parasite persistence?
@ast
Chagas disease etiology: autoimmunity or parasite persistence?
@en
type
label
Chagas disease etiology: autoimmunity or parasite persistence?
@ast
Chagas disease etiology: autoimmunity or parasite persistence?
@en
prefLabel
Chagas disease etiology: autoimmunity or parasite persistence?
@ast
Chagas disease etiology: autoimmunity or parasite persistence?
@en
P1476
Chagas disease etiology: autoimmunity or parasite persistence?
@en
P2093
P356
10.1016/S0169-4758(99)01398-8
P577
1999-03-01T00:00:00Z